Related Experiment Video
Updated: Aug 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal Cancer Screening at Younger Ages: A Multicutoff Analysis of FIT Performance
Julia Hibbert1, Teresa Seum1, Michael Hoffmeister2
1Division of Clinical Epidemiology of Early Cancer Detection, German Cancer Research Center (DKFZ), Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Fecal immunochemical tests (FIT) show variable diagnostic performance for advanced neoplasia (AN) in individuals under 55. This study provides data to optimize colorectal cancer (CRC) screening effectiveness and cost-efficiency in younger populations.
Area of Science:
- Gastroenterology
- Oncology
- Preventive Medicine
Background:
- Rising incidence of early-onset colorectal cancer (CRC) prompts consideration of lowering screening age.
- Limited data exists on the diagnostic performance of fecal immunochemical tests (FIT) in younger populations.
- Assessing FIT performance in individuals aged 55 or younger is crucial for adapting screening strategies.
Purpose of the Study:
- To evaluate the diagnostic performance of FIT for detecting advanced neoplasia (AN) in individuals aged 55 or younger.
- To analyze FIT performance across various fecal hemoglobin (Hb) concentration cutoffs.
- To inform the optimization of CRC screening effectiveness and cost-efficiency in younger demographics.
Main Methods:
- A cross-sectional study of 1724 participants aged 55 or younger who underwent screening colonoscopy.
- Fecal Hb concentrations were measured using FIT (Sentinel FOB Gold) prior to colonoscopy.
- FIT performance metrics (positivity rate, sensitivity, specificity, PPV, NPV) were evaluated at different Hb thresholds.
Main Results:
- Advanced neoplasia (AN) was detected in 8.1% of participants, including 0.3% with CRC.
- At the recommended cutoff (17 µg Hb/g stool), FIT sensitivity was 26.6% and specificity was 94.0% for AN detection.
- Performance metrics varied significantly across different Hb cutoffs, with men showing higher prevalence and detection rates.
Conclusions:
- The study provides detailed quantitative data on FIT's diagnostic performance in a younger CRC screening population.
- Findings can inform and optimize the effectiveness and cost-efficiency of CRC screening at younger ages.
- Further research may refine FIT utilization for early detection in at-risk younger individuals.
Related Concept Videos
Cancer Prevention
Some...
Longitudinal Research
Cancer Survival Analysis
